Valo Therapeutics receives $4.6 million funding to accelerate development of a novel oncolytic virus-based cancer immunotherapy Read more about Valo Therapeutics receives $4.6 million funding to accelerate development of a novel oncolytic virus-based cancer immunotherapy
Dispute over EUR 27 million annual subscription costs for scientific journals Read more about Dispute over EUR 27 million annual subscription costs for scientific journals
Traumatic brain injury associated with dementia in working-age adults Read more about Traumatic brain injury associated with dementia in working-age adults
New HiLIFE Proof of Concept Grants call is open Read more about New HiLIFE Proof of Concept Grants call is open
Alf Norkko honoured with Royal Baltic Sea professorship Read more about Alf Norkko honoured with Royal Baltic Sea professorship
The Ii Hamina cemetery reveals adaptation to the environment Read more about The Ii Hamina cemetery reveals adaptation to the environment